Metropolis Healthcare Ltd. ( (IN:METROPOLIS) ) has provided an announcement.
Metropolis Healthcare Ltd. announced the grant of 18,000 Restrictive Stock Units (RSUs) under its 2020 RSU Plan, approved by the Nomination and Remuneration Committee. This move is part of the company’s strategy to incentivize and retain its employees, potentially impacting its operational efficiency and employee satisfaction positively.
More about Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. operates in the healthcare industry, focusing on providing diagnostic services and healthcare solutions. The company is known for its comprehensive range of diagnostic tests and services, catering to the needs of patients and healthcare providers.
YTD Price Performance: -21.11%
Average Trading Volume: 5,367
Current Market Cap: 83.19B INR
For a thorough assessment of METROPOLIS stock, go to TipRanks’ Stock Analysis page.